CVS HEALTH Corp
CVSNYSERetail-Drug Stores and Proprietary StoresFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 12/3016% above fair value
$88.51−1.74 (-1.93%)
Close on Nov 2, 2026Market cap $113.20BP/E 23.5Yield 3.01%
Cvs Health Peer Benchmark by Quarter
Peer Benchmark — HCA Healthcare (HCA) & Labcorp (LH): Provider & Lab Revenues ($M)
Cvs Health Peer Benchmark: $19,109M in Q1 2026, up 4.3% from a year earlier.
Latest, Q1 2026
19,109
Period ended Mar 31, 2026
Change on a year earlier
+4.3%
18,321 in Q1 2025
History
21 quarters
Since Q1 2021
Sources
2
Documents cited below
Where the Q1 2026 figure comes from
Quarterly history
Hover a value to see the sentence it was read from; calculated values show their formula
Breakdown
What makes up peer Benchmark
Cite this data
StockData. (2026). Cvs Health Peer Benchmark ($M), quarterly Q1 2021–Q1 2026 [Data set]. Compiled from Cvs Health SEC filings and investor materials. https://stockdatahq.com/stocks/cvs/kpis/peer-hca-revenue
See every metric in the Cvs Health KPI table. Data updated Oct 28, 2026.